Telix Pharmaceuticals | TLX - Current Liabilities


Telix Pharmaceuticals reported AUD231.62M in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Cochlear AUD 558.9M 43.4M Dec/2025
CSL USD 4.61B 207M Dec/2025
Integral Diagnostics AUD 85.68M 388K Jun/2024
Mayne Pharma AUD 313.94M 18.28M Jun/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Mesoblast USD 128.07M 25.44M Dec/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Pacific Edge NZD 6.82M 400K Jun/2026
Paradigm Biopharmaceuticals AUD 16.6M 13.37M Dec/2025
Polynovo AUD 22.81M 5.07M Dec/2025
PYC Therapeutics AUD 11.01M 1.31M Dec/2025
Ramsay Health Care AUD 3.95B 514.2M Dec/2025
ResMed USD 1.35B 103.1M Mar/2026
Sonic Healthcare AUD 2.23B 92.84M Dec/2024